Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan-Fu Yu

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Rheumatology (Oxford, England)|December 20, 2011
Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidencesHan-Ming Lai, Chung-Jen Chen, Ben Yu-Jih Su, et al.
BMC Musculoskeletal Disorders|August 3, 2017
Delayed anti-TNF therapy increases the risk of total knee replacement in patients with severe rheumatoid arthritisYing-Chou Chen, Wen-Chan Chiu, Tien-Tsai Cheng, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced OsteoporosisJia-Feng Chen, Shan-Fu Yu, Wen-Chan Chiu, et al.
Frontiers in Medicine|June 27, 2022
The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis-A 3-Year Interim Analysis of a Longitudinal Observational Cohort StudyShan-Fu Yu, Jia-Feng Chen, Ying-Chou Chen, et al.
The Kaohsiung Journal of Medical Sciences|July 16, 2011
Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-upYen-Nung Liao, Ching-Shen Liu, Tong-Rong Tsai, et al.
Journal of Bone and Mineral Metabolism|February 5, 2013
Non-adherence to anti-osteoporotic medications in Taiwan: physician specialty makes a differenceShan-Fu Yu, Tsong-Shing Yang, Wen-Chan Chiu, et al.
Archives of Osteoporosis|October 26, 2019
The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS)Jia-Feng Chen, Shan-Fu Yu, Chung-Yuan Hsu, et al.
BMC Geriatrics|October 30, 2019
Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort studyShan-Fu Yu, Jur-Shan Cheng, Ying-Chou Chen, et al.
Rheumatology (Oxford, England)|October 14, 2017
Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort studyChung-Yuan Hsu, Yu-Sheng Lin, Yu-Jih Su, et al.
Diagnostics (Basel, Switzerland)|November 27, 2025
Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. <i>Diagnostics</i> 2024, <i>14</i>, 452Jia-Feng Chen, Shan-Fu Yu, Wen-Chan Chiu, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|December 20, 2011
Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidencesHan-Ming Lai, Chung-Jen Chen, Ben Yu-Jih Su, et al.
BMC Musculoskeletal Disorders|August 3, 2017
Delayed anti-TNF therapy increases the risk of total knee replacement in patients with severe rheumatoid arthritisYing-Chou Chen, Wen-Chan Chiu, Tien-Tsai Cheng, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced OsteoporosisJia-Feng Chen, Shan-Fu Yu, Wen-Chan Chiu, et al.
Frontiers in Medicine|June 27, 2022
The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis-A 3-Year Interim Analysis of a Longitudinal Observational Cohort StudyShan-Fu Yu, Jia-Feng Chen, Ying-Chou Chen, et al.
The Kaohsiung Journal of Medical Sciences|July 16, 2011
Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-upYen-Nung Liao, Ching-Shen Liu, Tong-Rong Tsai, et al.
Journal of Bone and Mineral Metabolism|February 5, 2013
Non-adherence to anti-osteoporotic medications in Taiwan: physician specialty makes a differenceShan-Fu Yu, Tsong-Shing Yang, Wen-Chan Chiu, et al.
Archives of Osteoporosis|October 26, 2019
The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS)Jia-Feng Chen, Shan-Fu Yu, Chung-Yuan Hsu, et al.
BMC Geriatrics|October 30, 2019
Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort studyShan-Fu Yu, Jur-Shan Cheng, Ying-Chou Chen, et al.
Rheumatology (Oxford, England)|October 14, 2017
Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort studyChung-Yuan Hsu, Yu-Sheng Lin, Yu-Jih Su, et al.
Diagnostics (Basel, Switzerland)|November 27, 2025
Correction: Chen et al. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. <i>Diagnostics</i> 2024, <i>14</i>, 452Jia-Feng Chen, Shan-Fu Yu, Wen-Chan Chiu, et al.
Pageof 5